Chiari Malformation Type I: What Referring Physicians Should Recognize Before Symptoms Progress

July 7, 2026
Fabio Frisoli, MD

At Atlantic Health, neurosurgeon Fabio Frisoli, MD, discusses the evaluation and management of Chiari malformation type I, emphasizing that clinical symptoms and neurologic findings—not imaging alone—should guide treatment decisions. Read to learn more.

 

Chiari malformation type I is not a rare diagnosis, but it is often a misunderstood one

With the widespread use of MRI, incidental findings of cerebellar tonsillar descent are increasingly common. Estimates suggest that Chiari type I malformation may be present in up to 1% of the population, though only a subset of those patients will ever become symptomatic. For referring physicians, that creates a familiar challenge. You may see it on a report, but determining what it means for the patient in front of you is less straightforward. 

At Atlantic Health, neurosurgeon Fabio Frisoli, MD approaches Chiari malformation with a clear distinction in mind. 

“The diagnosis itself is not the issue,” Dr. Frisoli said. “The question is whether that anatomy is actually causing symptoms and affecting the patient’s day-to-day life.” 

What Is Chiari Malformation, and Why Does It Matter 

Chiari malformation type I is a structural abnormality at the base of the skull. It occurs when the cerebellar tonsils extend downward through the foramen magnum into the upper spinal canal. This creates crowding at the craniovertebral junction and can disrupt the normal flow of cerebrospinal fluid. 

That disruption is what drives symptoms. 

“The space at the base of the skull is simply too tight,” Dr. Frisoli explained. “Over time, that can put pressure on the brainstem and upper spinal cord, and interfere with how cerebrospinal fluid circulates.” 

Importantly, not all patients experience symptoms. Many live for years without any clinical impact. Others develop progressive complaints that can significantly affect quality of life. 

Understanding that spectrum is critical for providers who are often the first to evaluate these patients. 

How Chiari Malformation Typically Presents 

The most common presenting symptom remains a suboccipital headache, often with a very specific pattern. 

“Patients will describe pain in the back of the head that worsens with coughing, sneezing, or bending forward,” Dr. Frisoli said. “That Valsalva component is one of the key features that raises suspicion.” 

These headaches are frequently misattributed early on. Patients may be treated for tension headaches or migraines before the underlying cause is recognized. 

As the condition progresses, symptoms can extend beyond pain. 

Patients may report: 

• Numbness or tingling in the shoulders, arms, or hands  

• Weakness in the upper extremities  

• Difficulty with coordination or balance  

In more advanced cases, a syrinx can develop within the spinal cord. 

“When you start to see a syrinx, that’s when the stakes change,” Dr. Frisoli said. “It’s a sign that cerebrospinal fluid flow has been disrupted enough to affect the spinal cord itself.” 

That can lead to more persistent neurologic deficits if left untreated. 

Why Imaging Doesn’t Tell the Whole Story 

MRI is essential for diagnosis, but it does not define severity on its own. 

“We’ve seen patients with significant tonsillar descent who have very minimal symptoms, and others with less dramatic imaging who are quite symptomatic,” Dr. Frisoli said. “So you have to interpret imaging in the context of the patient, not in isolation.” 

For referring providers, this is where clinical judgment becomes critical. 

An incidental Chiari finding without symptoms does not require urgent referral. At the same time, patients with clear symptom patterns may warrant evaluation even if imaging appears modest. 

When Symptoms Signal the Need for Evaluation 

While many patients can be safely observed, there are clear scenarios where further evaluation is appropriate. 

Patients who experience persistent, Valsalva-induced headaches that interfere with daily life should be considered for referral. The same is true for those who develop neurologic symptoms, including sensory changes or weakness. 

The presence of a syrinx is another important trigger. 

“That tells us the physiology is being affected, not just the anatomy,” Dr. Frisoli said. “Those patients need to be evaluated more closely.” 

In general, progression matters. Worsening symptoms over time, even if subtle, suggest that the underlying compression is having a cumulative effect. 

The Role of Conservative Management 

There is a role for observation in many patients, particularly those with mild or stable symptoms. 

“There are patients we follow for years without ever recommending surgery,” Dr. Frisoli said. “If it’s not impacting their quality of life, we don’t need to intervene.” 

In select cases, short-term medical management may be used to help control symptoms. Medications that reduce cerebrospinal fluid production can provide temporary relief, but they do not address the underlying structural issue. 

For patients with persistent or progressive symptoms, surgery remains the only definitive option. 

A Collaborative Approach to Referral 

For referring physicians, the goal of a neurosurgical referral is not to automatically move toward intervention. It is to gain clarity. 

At Atlantic Health, that evaluation focuses on correlating symptoms with imaging, assessing risk of progression, and determining whether a patient is likely to benefit from decompression. 

“We spend a lot of time making sure the symptoms truly match the diagnosis,” Dr. Frisoli said. “That’s what ultimately guides whether surgery is the right next step.” 

Communication with referring providers is a key part of that process. Patients are evaluated, recommendations are shared, and care remains coordinated. 

Clinical Perspective for Referring Providers 

Chiari malformation type I is often identified incidentally, but its clinical significance varies widely. 

For referring physicians, the most important step is recognizing when the condition is no longer just an imaging finding, but a source of meaningful symptoms or neurologic change. 

“When symptoms are progressive or affecting daily life, that’s when we start thinking about intervention,” Dr. Frisoli said. “The timing of that evaluation can make a real difference for patients.” 

Read More Neuroscience Content